Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lookstein, R. A
Right arrow Articles by Marin, M. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lookstein, R. A
Right arrow Articles by Marin, M. L
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

case-report

Sirolimus-eluting stent placement for refractory renal artery in-stent restenosis: sustained patency and clinical benefit at 24 months

Robert A Lookstein

Division of Interventional Radiology, Mount Sinai School of Medicinerobert.lookstein{at}msnyuhealth.org

Adam D Talenfeld

Division of Interventional Radiology, Mount Sinai School of Medicine

Roman Raju

Division of Interventional Radiology, Mount Sinai School of Medicine

David A Vorchheimer

Division of Cardiology, Mount Sinai School of Medicine

Jeffrey W Olin

Division of Cardiology, Mount Sinai School of Medicine

Michael L Marin

Division of Vascular Surgery, Mount Sinai School of Medicine

Abstract

Renal artery stenosis may cause or exacerbate hypertension and renal failure. Percutaneous transluminal renal artery stent placement, increasingly the first-line therapy for ostial atherosclerotic renal artery stenosis, can be complicated by in-stent restenosis weeks to months after the procedure. There is currently no consensus for the treatment of in-stent restenosis. Sirolimus-eluting stents have been shown to be effective to treat in-stent restenosis in the coronary circulation. We report a case of sustained 24-month patency after repair of recurrent renal artery in-stent restenosis with use of a sirolimus-eluting stent.

Key Words: drug-eluting stent • in-stent stenosis • renal artery stent • treatment

Vascular Medicine, Vol. 14, No. 4, 361-364 (2009)
DOI: 10.1177/1358863X08102001
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?